Castle Biosciences Inc (CSTL)
New Data Confirms Performance of DecisionDx®-Melanoma to Identify Patients with Less Than Five Percent Risk of Sentinel Lymph Node Positivity
Marker Therapeutics Inc. (MRKR)
Marker Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates
Iterum Therapeutics plc (ITRM)
Iterum Therapeutics Reports Third Quarter 2025 Financial Results
Scholar Rock Holding Corp (SRRK)
Scholar Rock Reports Third Quarter 2025 Financial Results and Recent Business Highlights
SATELLOS BIOSCIENCE INC. (MSCLF)
Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Bristol-Myers Squibb Co. (BMYMP)
Update on Phase 3 Librexia ACS Trial
Bristol-Myers Squibb Company (BMY)
Update on Phase 3 Librexia ACS Trial
Merck & Company Inc (MRK)
Merck to Acquire Cidara Therapeutics, Inc., Diversifying Its Portfolio to Include Late-Phase Antiviral Agent
Teleflex Incorporated (TFX)
Teleflex - Teleflex to Present at the Jefferies Global Healthcare Conference in London
Embecta Corp (EMBC)
embecta Announces Major New Commitment to Direct Relief on World Diabetes Day